AJP - Heart AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 281: H2490-H2499, 2001;
0363-6135/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vinge, L. E.
Right arrow Articles by Attramadal, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vinge, L. E.
Right arrow Articles by Attramadal, H.
Vol. 281, Issue 6, H2490-H2499, December 2001

Myocardial distribution and regulation of GRK and beta -arrestin isoforms in congestive heart failure in rats

Leif Erik Vinge1,2, Erik Øie1,2, Yvonne Andersson1,2, Haakon K. Grøgaard1, Geir Ø. Andersen2,3, and Håvard Attramadal1,2

1 Institute for Surgical Research, 2 MerckSharp & Dohme Cardiovascular Research Center, and 3 Department of Pharmacology, Rikshospitalet University Hospital, University of Oslo, N-0027 Oslo, Norway

Myocardial G protein-coupled receptor kinase 2 (GRK2) has been shown to be involved in the pathophysiology of congestive heart failure (CHF). However, the cellular distribution of this isoform, as well as the other isoforms of the GRK-arrestin system, has not been studied in myocardial tissue. Thus myocardial expression and cellular distribution of the different GRK and arrestin isoforms were investigated in a rat model of CHF. Rats subjected to ligation of the left coronary artery or sham operation were euthanized 2, 7, or 42 days after the surgical procedure. Myocardial GRK2, GRK5, beta -arrestin-1, and beta -arrestin-2 mRNA levels, but not that of GRK3, were induced in the failing hearts. Consistently, Western blot analysis of tissue extracts from the nonischemic region of the left ventricle revealed 3.0-, 2.6-, and 1.5-fold elevations of GRK2, GRK5, and beta -arrestin-1, respectively, 7 days after induction of myocardial infarction compared with the sham-operated rats (P < 0.05). Immunohistochemical analysis of myocardial tissue sections and Western blot analysis of isolated cells revealed localization of GRK2 and beta -arrestin-1 predominantly in endothelial cells. Conversely, GRK3 was confined to cardiac myocytes. GRK5 immunostaining appeared to be homogeneously distributed in the cellular elements of the myocardium. In conclusion, myocardial mRNA and protein levels of GRK2, GRK5, and beta -arrestin-1 are induced in postinfarction failure in rats. The immunohistochemical analysis suggests that GRK2 and beta -arrestin-1 may act as primary regulators of endothelial function. Conversely, the cellular distribution of GRK3 and GRK5 implicates these isoforms as putative regulators of cardiac myocyte function.

gene expression; immunohistochemistry; G protein-coupled receptor kinase


This article has been cited by other articles:


Home page
 Circ. Res.Home page
P. W. Raake, L. E. Vinge, E. Gao, M. Boucher, G. Rengo, X. Chen, B. R. DeGeorge Jr, S. Matkovich, S. R. Houser, P. Most, et al.
G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure
Circ. Res., August 15, 2008; 103(4): 413 - 422.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
L. E. Vinge, P. W. Raake, and W. J. Koch
Gene Therapy in Heart Failure
Circ. Res., June 20, 2008; 102(12): 1458 - 1470.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. S. Fernandez-Twinn, S. Ekizoglou, A. Wayman, C. J. Petry, and S. E. Ozanne
Maternal low-protein diet programs cardiac beta-adrenergic response and signaling in 3-mo-old male offspring
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R429 - R436.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. M. Dhahbi, T. Tsuchiya, H.-J. Kim, P. L. Mote, and S. R. Spindler
Gene expression and physiologic responses of the heart to the initiation and withdrawal of caloric restriction.
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2006; 61(3): 218 - 231.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Penela, C. Murga, C. Ribas, A. S. Tutor, S. Peregrin, and F. Mayor Jr.
Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease
Cardiovasc Res, January 1, 2006; 69(1): 46 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Wang, E. Sentex, H. K. Saini, D. Chapman, and N. S. Dhalla
Upregulation of {beta}-adrenergic receptors in heart failure due to volume overload
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H151 - H159.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. Leineweber, P. Rohe, A. Beilfuss, C. Wolf, H. Sporkmann, H. Bruck, H.-G. Jakob, G. Heusch, T. Philipp, and O.-E. Brodde
G-protein-coupled receptor kinase activity in human heart failure: Effects of {beta}-adrenoceptor blockade
Cardiovasc Res, June 1, 2005; 66(3): 512 - 519.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. S. Ahmed, E. Oie, L. E. Vinge, A. Yndestad, G. O. Andersen, Y. Andersson, T. Attramadal, and H. Attramadal
Induction of myocardial biglycan in heart failure in rats--an extracellular matrix component targeted by AT1 receptor antagonism
Cardiovasc Res, December 1, 2003; 60(3): 557 - 568.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online